Skip to main content
SP5007,652.86-0.28%DOW53,417.16+0.26%NASDAQ25,980.19-0.76%BTC$79,623.00+2.76%ETH$2,494.81+1.53%GOLD$4,751.30+1.14%OIL$84.91-0.12%
Smart Investors Daily
Sign InSign Up Free
BC

NASDAQ · BCTXZ

BriaCell Therapeutics Corp. Warrant

Healthcare · Biotechnology

$0.11

Up+$0.01 (+4.76%)

Updated Aug 25, 2026, 2:12 AM

SID Score

4.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
753.16K
P/E ratio
-1.99
Dividend yield
0.00%
52-week range
$0.06 – $0.17
Volume
34.64K
Avg. volume
21.5K

Price performance

BCTXZ price history

1M range · 21 trading sessions · Daily adjusted prices

BCTXZ closed at $0.11 after 21 trading sessions, up 22.22% for the selected period.

Last close
$0.11
Period change
+22.22%
Period low
$0.09
Period high
$0.11
Daily close
View OHLC price history
BCTXZ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 24, 2026$0.12$0.14$0.1059$0.1134.64K
Aug 21, 2026$0.112$0.1731$0.105$0.10537.64K
Aug 20, 2026$0.11$0.119$0.0954$0.1024117.65K
Aug 19, 2026$0.1129$0.119$0.09$0.1142172.87K
Aug 18, 2026$0.1075$0.1145$0.0995$0.112990.31K
Aug 17, 2026$0.11$0.1142$0.1046$0.109965.13K
Aug 14, 2026$0.115$0.12$0.0903$0.11109.96K
Aug 13, 2026$0.13$0.1315$0.10$0.1179.74K
Aug 12, 2026$0.0999$0.1367$0.0852$0.103169.01K
Aug 11, 2026$0.105$0.125$0.0851$0.0999215.35K
Aug 10, 2026$0.1071$0.1071$0.0826$0.0971302.72K
Aug 7, 2026$0.0897$0.0946$0.0796$0.0892392.33K
Aug 6, 2026$0.0835$0.0869$0.0801$0.086892.78K
Aug 5, 2026$0.085$0.0889$0.0725$0.0868124.12K
Aug 4, 2026$0.0852$0.095$0.0801$0.08998.72K
Aug 3, 2026$0.0898$0.1074$0.0698$0.0899244.87K
Jul 31, 2026$0.09$0.095$0.0702$0.0899129.48K
Jul 30, 2026$0.0919$0.0919$0.0871$0.08711.65K
Jul 29, 2026$0.10$0.10$0.0832$0.0919165.9K
Jul 28, 2026$0.09$0.1075$0.0831$0.09289.06K
Jul 27, 2026$0.0995$0.0997$0.0832$0.09163.89K

Latest BCTXZ news

The latest Smart Investors Daily articles mentioning BCTXZ.

Stock researchCompany · Overview

BCTXZ research

Overview

Company profile and research snapshot.

Company profile

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jun 25, 2026

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is designed to support faster, more convenient administration while enhancing the patient and provider experience Bria-IMT is currently being evaluated in BriaCell’s ongoing pivotal Phase 3 study in advanced metastatic breast cancer PHILADELPHIA and VANCOUVER, British Columbia, June 25

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By